Abstract
NMDA-type glutamate receptors (NMDARs) are currently regarded as paramount in the potent and selective disruption of synaptic plasticity by Alzheimer's disease amyloid β-protein (Aβ). Non-NMDAR mechanisms remain relatively unexplored. Here we describe how Aβ facilitates NMDAR-independent long-term depression of synaptic transmission in the hippocampus in vivo. Synthetic Aβ and Aβ in soluble extracts of Alzheimer's disease brain usurp endogenous acetylcholine muscarinic receptor-dependent long-term depression, to enable long-term depression that required metabotropic glutamate-5 receptors (mGlu5Rs). We also find that mGlu5Rs are essential for Aβ-mediated inhibition of NMDAR-dependent long-term potentiation in vivo. Blocking Aβ binding to cellular prion protein with antibodies prevents the facilitation of long-term depression. Our findings uncover an overarching role for Aβ-PrPC-mGlu5R interplay in mediating both LTD facilitation and LTP inhibition, encompassing NMDAR-mediated processes that were previously considered primary. © 2014 Macmillan Publishers Limited.
Cite
CITATION STYLE
Hu, N. W., Nicoll, A. J., Zhang, D., Mably, A. J., O’Malley, T., Purro, S. A., … Rowan, M. J. (2014). MGlu5 receptors and cellular prion protein mediate amyloid-β- facilitated synaptic long-term depression in vivo. Nature Communications, 5. https://doi.org/10.1038/ncomms4374
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.